UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

The Lancet (British edition), 2020-12, Vol.396 (10265), p.1817-1828

2020

Volltextzugriff (PDF)

PP01.127 A rare case of pulmonary enteric adenocarcinoma in a 26-year-old female non-smoker

Journal of thoracic oncology, 2024-07, Vol.19 (7), p.e55-e56

2024

Volltextzugriff (PDF)

Intensity-Modulated Radiation Therapy in Breast Cancer Patients Following the Release of a Choosing Wisely Recommendation

JNCI : Journal of the National Cancer Institute, 2020-03, Vol.112 (3), p.314-317

2020

Volltextzugriff (PDF)

Obesity and cancer treatment efficacy: Existing challenges and opportunities

Cancer, 2019-05, Vol.125 (10), p.1588-1592

2019

Volltextzugriff (PDF)

A spatial attention guided deep learning system for prediction of pathological complete response using breast cancer histopathology images

Bioinformatics (Oxford, England), 2022-09, Vol.38 (19), p.4605-4612

2022

Volltextzugriff (PDF)

Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer

International journal of epidemiology, 2019-12, Vol.48 (6), p.1897-1905

2019

Volltextzugriff (PDF)

A multicenter phase II study of vaccines to prevent recurrence in patients with HER-2–positive breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.532-532

2023

Volltextzugriff (PDF)

Outcomes for black versus white women with stage IV breast cancer enrolled on investigator-initiated clinical trials at Emory

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1086-1086

2020

Volltextzugriff (PDF)

Drivers of racial, regional, and socioeconomic disparities in late‐stage breast cancer mortality

Cancer, 2022-09, Vol.128 (18), p.3370-3382

2022

Volltextzugriff (PDF)

Abstract 4247: Racial/ethnic differences in all-cause and cause-specific mortality patterns among a cohort of invasive U.S. breast cancer patients

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4247-4247

2018

Volltextzugriff (PDF)

Barriers to breast cancer screening in Atlanta, GA: results from the Pink Panel survey at faith-based institutions

Cancer causes & control, 2022-12, Vol.33 (12), p.1465-1472

2022

Volltextzugriff (PDF)

Abstract 3298: Oncotype DX recurrence score: Implications for disparities in receipt of chemotherapy and breast cancer-specific mortality in Georgia

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3298-3298

2019

Volltextzugriff (PDF)

Abstract B34: Patterns of BRCA testing at a safety net compared to a university hospital

Cancer epidemiology, biomarkers & prevention, 2018-07, Vol.27 (7_Supplement), p.B34-B34

2018

Volltextzugriff (PDF)

Abstract OT1-16-01: A multicenter phase II study of vaccines to prevent recurrence in patients with HER-2 positive breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT1-16-01-OT1-16-01

2022

Volltextzugriff (PDF)

Improving provider practice patterns in ordering FDG PET/CT for breast cancer patients at a safety-net hospital

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e14027-e14027

2020

Volltextzugriff (PDF)

Abstract PR-03: Neighborhood-level redlining-associated methylation in breast tumors: The impact of structural racism on the tumor epigenome

Cancer epidemiology, biomarkers & prevention, 2022-01, Vol.31 (1_Supplement), p.PR-03-PR-03

2022

Volltextzugriff (PDF)

Abstract CT173: Sunitinib (S) in patients (pts) with metastatic breast cancer (mBC) with FGFR1 mutations or amplifications: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT173-CT173

2021

Volltextzugriff (PDF)

Saci-IO HR+: Randomized phase II trial of sacituzumab govitecan (SG) +/- pembrolizumab in PD-L1+ hormone receptor-positive (HR+) / HER2- metastatic breast cancer (MBC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS1102-TPS1102

2021

Volltextzugriff (PDF)

Study Protocol: Efficacy and Safety of Radioembolization (REM) as an Early Modality (EM) Therapy for Metastatic Breast Cancer (BR) to the Liver with Y90 (REMEMBR Y90)

Cardiovascular and interventional radiology, 2022-11, Vol.45 (11), p.1725-1734

2022

Volltextzugriff (PDF)

Abstract PD13-02: Phase Ib expansion study of gedatolisib in combination with palbociclib and endocrine therapy in women with ER+ metastatic breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD13-02-PD13-02

2022

Volltextzugriff (PDF)

Molecular profiling and quantitative image analysis reveal spatial intratumor heterogeneity in TNBC

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e12536-e12536

2020

Volltextzugriff (PDF)

Abstract C074: Presence of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White breast cancer patients

Cancer epidemiology, biomarkers & prevention, 2020-06, Vol.29 (6_Supplement_2), p.C074-C074

2020

Volltextzugriff (PDF)

Abstract C053: Identification of factors contributing to breast cancer mortality disparities in the metropolitan Atlanta area

Cancer epidemiology, biomarkers & prevention, 2020-06, Vol.29 (6_Supplement_1), p.C053-C053

2020

Volltextzugriff (PDF)

Patient demand for care: How much does this contribute to inappropriate tests and treatments?

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.6530-6530

2014

Volltextzugriff (PDF)

Leveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial

JCO oncology practice, 2024-06

2024

Volltextzugriff (PDF)

26 – 50 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(76)
Buchkapitel
(1)

Sprache

Englisch
(77)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

PP01.127 A rare case of pulmonary enteric adenocarcinoma in a 26-year-old female non-smoker

Intensity-Modulated Radiation Therapy in Breast Cancer Patients Following the Release of a Choosing Wisely Recommendation

Obesity and cancer treatment efficacy: Existing challenges and opportunities

A spatial attention guided deep learning system for prediction of pathological complete response using breast cancer histopathology images

Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer

A multicenter phase II study of vaccines to prevent recurrence in patients with HER-2–positive breast cancer

Outcomes for black versus white women with stage IV breast cancer enrolled on investigator-initiated clinical trials at Emory

Drivers of racial, regional, and socioeconomic disparities in late‐stage breast cancer mortality

Abstract 4247: Racial/ethnic differences in all-cause and cause-specific mortality patterns among a cohort of invasive U.S. breast cancer patients

Barriers to breast cancer screening in Atlanta, GA: results from the Pink Panel survey at faith-based institutions

Abstract 3298: Oncotype DX recurrence score: Implications for disparities in receipt of chemotherapy and breast cancer-specific mortality in Georgia

Abstract B34: Patterns of BRCA testing at a safety net compared to a university hospital

Abstract OT1-16-01: A multicenter phase II study of vaccines to prevent recurrence in patients with HER-2 positive breast cancer

Improving provider practice patterns in ordering FDG PET/CT for breast cancer patients at a safety-net hospital

Abstract PR-03: Neighborhood-level redlining-associated methylation in breast tumors: The impact of structural racism on the tumor epigenome

Abstract CT173: Sunitinib (S) in patients (pts) with metastatic breast cancer (mBC) with FGFR1 mutations or amplifications: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Saci-IO HR+: Randomized phase II trial of sacituzumab govitecan (SG) +/- pembrolizumab in PD-L1+ hormone receptor-positive (HR+) / HER2- metastatic breast cancer (MBC)

Study Protocol: Efficacy and Safety of Radioembolization (REM) as an Early Modality (EM) Therapy for Metastatic Breast Cancer (BR) to the Liver with Y90 (REMEMBR Y90)

Abstract PD13-02: Phase Ib expansion study of gedatolisib in combination with palbociclib and endocrine therapy in women with ER+ metastatic breast cancer

Molecular profiling and quantitative image analysis reveal spatial intratumor heterogeneity in TNBC

Abstract C074: Presence of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White breast cancer patients

Abstract C053: Identification of factors contributing to breast cancer mortality disparities in the metropolitan Atlanta area

Patient demand for care: How much does this contribute to inappropriate tests and treatments?

Leveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial

Suchergebnisse filtern